Kiromic Biopharma, Inc. Email Format

Biotechnology ResearchTexas, United States11-50 Employees

Kiromic Biopharma, Inc. is a clinical-stage biotechnology company focused on immuno-oncology. It develops allogeneic gamma delta T-cell therapies aimed at addressing solid tumors, supported by a proprietary platform that blends bioinformatics, AI-based target discovery, and manufacturing capabilities. The approach seeks to compress development timelines and costs by integrating data-driven discovery with scalable cell therapy production.

Based in Houston, Texas, Kiromic operates within the biotechnology research sector and pursues a multi-indication cell therapy platform. Recent media coverage notes Kiromic is pursuing off-the-shelf gamma delta T-cell therapies, reflecting a focus on scalable allogeneic approaches.

Get verified Kiromic Biopharma, Inc. emails free

Company overview Employee directory